Top Stock Gainers Today

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  25 Sep 2025
 

•   CPOP  
   
  0.00%
•   EPOW  
   
  0.00%
•   PEPG  
   
  0.00%
•   SPRC  
   
  0.00%
•   XXII  
   
  0.00%

$PEPG dominated the gainers list with a staggering 121% surge to $5.88, propelled by multiple catalysts converging simultaneously. The clinical-stage biotech company released groundbreaking data showing record-breaking splicing correction results in Duchenne muscular dystrophy patients, a development that immediately captured market attention. Trading volume exploded to 124 million shares compared to the typical 1.7 million average, signaling intense institutional and retail interest. The company capitalized on momentum by announcing a $100 million public offering, which paradoxically drove shares even higher as investors interpreted the capital raise as validation of the clinical progress. PepGen ability to achieve the highest splicing correction ever recorded in dystrophy patients represents a genuine scientific breakthrough that could reshape treatment paradigms. However, the massive run and dilutive offering create near-term overhead resistance that traders should monitor carefully.

$SPRC rallied 59% to $6.09 after unveiling an ambitious quantum computing-enabled 3D protein modeling initiative designed to revolutionize AI-powered drug discovery. The Tel Aviv-based specialty clinical company is positioning itself at the intersection of quantum computing and pharmaceutical development, a sector attracting significant venture capital and institutional attention. Volume reached nearly 89 million shares against a 5.36 million average, demonstrating the market's enthusiasm for innovative technology applications in healthcare. The quantum computing angle particularly resonated with investors given the broader market fascination with AI and next-generation computational capabilities. While the announcement represents strategic positioning rather than immediate revenue generation, the stock technical breakout suggests traders are betting on SciSparc ability to commercialize this technology partnership.

$CPOP surged 46% to $2.05 following the company's announcement of plans to accumulate 1,000 Bitcoin while entering what management describes as a trillion-dollar crypto entertainment market. Pop Culture Group's pivot toward cryptocurrency holdings mirrors the successful corporate Bitcoin treasury strategy employed by companies like MicroStrategy, though on a smaller scale. The Hong Kong-based company is attempting to bridge traditional entertainment business with digital asset accumulation, a hybrid model that appeals to investors seeking both crypto exposure and operational business fundamentals. Volume spiked to 59 million shares from a 958,000 average, indicating significant speculative interest. The timing coincides with renewed institutional interest in Bitcoin, making the announcement particularly well-positioned to capture momentum.

$EPOW jumped 38% to $1.12 after Sunrise New Energy reported a strong operational turnaround with over $570,000 in profits achieved during July and August 2025. The profitability milestone marks a significant inflection point for a company that had previously struggled with consistent earnings. While the absolute profit figure appears modest, the percentage gain and trend reversal caught the attention of value-oriented traders searching for turnaround stories in the renewable energy sector. Volume remained relatively light at 847,000 shares compared to a 26,550 average, suggesting the move could extend if broader awareness develops. The renewable energy backdrop remains favorable given policy support and infrastructure investment trends, potentially providing fundamental tailwinds beyond the immediate catalyst.

$XXII climbed 31% to $1.98 in premarket trading after 22nd Century Group disclosed a $9.5 million insurance settlement that resolves outstanding business disputes. The settlement provides immediate cash infusion and eliminates legal uncertainty that had weighed on the stock. Volume reached 20.8 million shares against a 1.55 million average, reflecting relief rally dynamics as investors reassess the company's financial position. The insurance proceeds could fund operational initiatives or reduce debt, improving the balance sheet materially for a small-cap company. The premarket strength suggests continued momentum into regular trading, though profit-taking after such rapid gains remains a risk factor.

View All Headlines